help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wisniewski, T.
Right arrow Articles by Frangione, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wisniewski, T.
Right arrow Articles by Frangione, B.

American Journal of Pathology, Vol 145, 1030-1035, Copyright © 1994 by American Society for Investigative Pathology

REGULAR ARTICLES

Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro

T Wisniewski, EM Castano, A Golabek, T Vogel and B Frangione
Department of Pathology, New York University Medical Center, NY 10016.

Numerous studies have established a linkage between the apolipoprotein (apo) E4 allele and late-onset Alzheimer's disease. It remains unclear if apo E plays a direct role in the pathogenesis of Alzheimer's disease and what, if any, are its significant interactions with amyloid beta (A beta) and tau. Apo E has been found immunohistochemically in all types of amyloid deposits and apo E fragments have been isolated from amyloid. Furthermore, apo E has been shown to bind soluble A beta. It has been proposed that apo E acts to promote and/or modulate A beta fibril formation. It is well established that peptides homologous to A beta will form amyloid-like fibrils in solution. With the use of electron microscopy and a thioflavin T assay for fibril formation we found that apo E and apo E4 in particular enhance this spontaneous fibrillogenesis of A beta peptides under the in vitro conditions used. These in vitro data suggest that the apo E4 isoform is a risk factor for Alzheimer's disease that acts to accelerate a process that can occur in its absence.


This article has been cited by other articles:


Home page
 J. Neurosci.Home page
F. Xu, M. P. Vitek, C. A. Colton, M. L. Previti, N. Gharkholonarehe, J. Davis, and W. E. Van Nostrand
Human Apolipoprotein E Redistributes Fibrillar Amyloid Deposition in Tg-SwDI Mice
J. Neurosci., May 14, 2008; 28(20): 5312 - 5320.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
Q. Xu, D. Walker, A. Bernardo, J. Brodbeck, M. E. Balestra, and Y. Huang
Intron-3 Retention/Splicing Controls Neuronal Expression of Apolipoprotein E in the CNS
J. Neurosci., February 6, 2008; 28(6): 1452 - 1459.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
H.-g. Lee, X. Zhu, R. J. Castellani, A. Nunomura, G. Perry, and M. A. Smith
Amyloid-beta in Alzheimer Disease: The Null versus the Alternate Hypotheses
J. Pharmacol. Exp. Ther., June 1, 2007; 321(3): 823 - 829.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. D. Hoos, M. Ahmed, S. O. Smith, and W. E. Van Nostrand
Inhibition of Familial Cerebral Amyloid Angiopathy Mutant Amyloid beta-Protein Fibril Assembly by Myelin Basic Protein
J. Biol. Chem., March 30, 2007; 282(13): 9952 - 9961.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
E. M REIMAN
Linking Brain Imaging and Genomics in the Study of Alzheimer's Disease and Aging
Ann. N.Y. Acad. Sci., February 1, 2007; 1097(1): 94 - 113.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. J. Sadowski, J. Pankiewicz, H. Scholtzova, P. D. Mehta, F. Prelli, D. Quartermain, and T. Wisniewski
Blocking the apolipoprotein E/amyloid-beta interaction as a potential therapeutic approach for Alzheimer's disease
PNAS, December 5, 2006; 103(49): 18787 - 18792.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
J. Padmanabhan, M. Levy, D. W. Dickson, and H. Potter
Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons
Brain, November 1, 2006; 129(11): 3020 - 3034.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C.-Y. Chou, W.-P. Jen, Y.-H. Hsieh, M.-S. Shiao, and G.-G. Chang
Structural and Functional Variations in Human Apolipoprotein E3 and E4
J. Biol. Chem., May 12, 2006; 281(19): 13333 - 13344.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
Q. Xu, A. Bernardo, D. Walker, T. Kanegawa, R. W. Mahley, and Y. Huang
Profile and Regulation of Apolipoprotein E (ApoE) Expression in the CNS in Mice with Targeting of Green Fluorescent Protein Gene to the ApoE Locus.
J. Neurosci., May 10, 2006; 26(19): 4985 - 4994.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
K.-A. Rye, R. Bright, M. Psaltis, and P. J. Barter
Regulation of reconstituted high density lipoprotein structure and remodeling by apolipoprotein E
J. Lipid Res., May 1, 2006; 47(5): 1025 - 1036.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
R. W. Mahley, K. H. Weisgraber, and Y. Huang
Inaugural Article: Apolipoprotein E4: A causative factor and therapeutic target in neuropathology, including Alzheimer's disease
PNAS, April 11, 2006; 103(15): 5644 - 5651.
[Abstract] [Full Text] [PDF]

Home page
 Sci Aging Knowl EnvironHome page
D. R. Thal, E. Capetillo-Zarate, K. Del Tredici, and H. Braak
The Development of Amyloid beta Protein Deposits in the Aged Brain
Sci. Aging Knowl. Environ., March 8, 2006; 2006(6): re1 - re1.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
Y. Huang
Apolipoprotein E and Alzheimer disease
Neurology, January 24, 2006; 66(1_suppl_1): S79 - S85.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. Chang, T. r. Ma, R. D. Miranda, M. E. Balestra, R. W. Mahley, and Y. Huang
Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity
PNAS, December 20, 2005; 102(51): 18694 - 18699.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
D A Bennett, J A Schneider, R S Wilson, J L Bienias, E Berry-Kravis, and S E Arnold
Amyloid mediates the association of apolipoprotein E e4 allele to cognitive function in older people
J. Neurol. Neurosurg. Psychiatry, September 1, 2005; 76(9): 1194 - 1199.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
A. Scuteri, S. S. Najjar, D. Muller, R. Andres, C. H. Morrell, A. B. Zonderman, and E. G. Lakatta
apoE4 allele and the natural history of cardiovascular risk factors
Am J Physiol Endocrinol Metab, August 1, 2005; 289(2): E322 - E327.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
M. M. M. Wilhelmus, I. Otte-Holler, J. Davis, W. E. Van Nostrand, R. M. W. de Waal, and M. M. Verbeek
Apolipoprotein E Genotype Regulates Amyloid-{beta} Cytotoxicity
J. Neurosci., April 6, 2005; 25(14): 3621 - 3627.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
F. M. Harris, W. J. Brecht, Q. Xu, R. W. Mahley, and Y. Huang
Increased tau Phosphorylation in Apolipoprotein E4 Transgenic Mice Is Associated with Activation of Extracellular Signal-regulated Kinase: MODULATION BY ZINC
J. Biol. Chem., October 22, 2004; 279(43): 44795 - 44801.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
M. Sadowski, J. Pankiewicz, H. Scholtzova, J. A. Ripellino, Y. Li, S. D. Schmidt, P. M. Mathews, J. D. Fryer, D. M. Holtzman, E. M. Sigurdsson, et al.
A Synthetic Peptide Blocking the Apolipoprotein E/{beta}-Amyloid Binding Mitigates {beta}-Amyloid Toxicity and Fibril Formation in Vitro and Reduces {beta}-Amyloid Plaques in Transgenic Mice
Am. J. Pathol., September 1, 2004; 165(3): 937 - 948.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Q. Xu, W. J. Brecht, K. H. Weisgraber, R. W. Mahley, and Y. Huang
Apolipoprotein E4 Domain Interaction Occurs in Living Neuronal Cells as Determined by Fluorescence Resonance Energy Transfer
J. Biol. Chem., June 11, 2004; 279(24): 25511 - 25516.
[Abstract] [Full Text] [PDF]

Home page
 Sci Aging Knowl EnvironHome page
J. Raber
Androgens, ApoE, and Alzheimer's Disease
Sci. Aging Knowl. Environ., March 17, 2004; 2004(11): re2 - re2.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
W. J. Brecht, F. M. Harris, S. Chang, I. Tesseur, G.-Q. Yu, Q. Xu, J. Dee Fish, T. Wyss-Coray, M. Buttini, L. Mucke, et al.
Neuron-Specific Apolipoprotein E4 Proteolysis Is Associated with Increased Tau Phosphorylation in Brains of Transgenic Mice
J. Neurosci., March 10, 2004; 24(10): 2527 - 2534.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
F. M. Harris, I. Tesseur, W. J. Brecht, Q. Xu, K. Mullendorff, S. Chang, T. Wyss-Coray, R. W. Mahley, and Y. Huang
Astroglial Regulation of Apolipoprotein E Expression in Neuronal Cells: IMPLICATIONS FOR ALZHEIMER'S DISEASE
J. Biol. Chem., January 30, 2004; 279(5): 3862 - 3868.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
E. M. Reiman, K. Chen, G. E. Alexander, R. J. Caselli, D. Bandy, D. Osborne, A. M. Saunders, and J. Hardy
Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia
PNAS, January 6, 2004; 101(1): 284 - 289.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
F. M. Harris, W. J. Brecht, Q. Xu, I. Tesseur, L. Kekonius, T. Wyss-Coray, J. D. Fish, E. Masliah, P. C. Hopkins, K. Scearce-Levie, et al.
Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer's disease-like neurodegeneration and behavioral deficits in transgenic mice
PNAS, September 16, 2003; 100(19): 10966 - 10971.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. A. Morrow, D. M. Hatters, B. Lu, P. Hochtl, K. A. Oberg, B. Rupp, and K. H. Weisgraber
Apolipoprotein E4 Forms a Molten Globule. A POTENTIAL BASIS FOR ITS ASSOCIATION WITH DISEASE
J. Biol. Chem., December 20, 2002; 277(52): 50380 - 50385.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Z.-S. Ji, R. D. Miranda, Y. M. Newhouse, K. H. Weisgraber, Y. Huang, and R. W. Mahley
Apolipoprotein E4 Potentiates Amyloid beta Peptide-induced Lysosomal Leakage and Apoptosis in Neuronal Cells
J. Biol. Chem., June 7, 2002; 277(24): 21821 - 21828.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
G. P. Lim, T. Chu, F. Yang, W. Beech, S. A. Frautschy, and G. M. Cole
The Curry Spice Curcumin Reduces Oxidative Damage and Amyloid Pathology in an Alzheimer Transgenic Mouse
J. Neurosci., November 1, 2001; 21(21): 8370 - 8377.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
A. Stephan, S. Laroche, and S. Davis
Generation of Aggregated {beta}-Amyloid in the Rat Hippocampus Impairs Synaptic Transmission and Plasticity and Causes Memory Deficits
J. Neurosci., August 1, 2001; 21(15): 5703 - 5714.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
Y. Huang, X. Q. Liu, T. Wyss-Coray, W. J. Brecht, D. A. Sanan, and R. W. Mahley
Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons
PNAS, July 5, 2001; (2001) 151254698.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
L. N. G. Nilsson, K. R. Bales, G. DiCarlo, M. N. Gordon, D. Morgan, S. M. Paul, and H. Potter
{alpha}-1-Antichymotrypsin Promotes {beta}-Sheet Amyloid Plaque Deposition in a Transgenic Mouse Model of Alzheimer's Disease
J. Neurosci., March 1, 2001; 21(5): 1444 - 1451.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
M. C. IRIZARRY, G. W. REBECK, B. CHEUNG, K. BALES, S. M PAUL, D. HOLZMAN, and B. T. HYMAN
Modulation of A{beta} Deposition in APP Transgenic Mice by an Apolipoprotein E Null Background
Ann. N.Y. Acad. Sci., December 1, 2000; 920(1): 171 - 178.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
B. T. Hyman, D. Strickland, and G. W. Rebeck
Role of the Low-density Lipoprotein Receptor-Related Protein in {beta}-Amyloid Metabolism and Alzheimer Disease
Arch Neurol, May 1, 2000; 57(5): 646 - 650.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
M. M. VERBEEK, W. E. VAN NOSTRAND, I. OTTE-HOLLER, P. WESSELING, and R. M. W. DE WAAL
Amyloid-{beta}-induced Degeneration of Human Brain Pericytes Is Dependent on the Apolipoprotein E Genotype
Ann. N.Y. Acad. Sci., April 1, 2000; 903(1): 187 - 199.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
P. Kuner, B. Bohrmann, L. O. Tjernberg, J. Naslund, G. Huber, S. Celenk, F. Gruninger-Leitch, J. G. Richards, R. Jakob-Roetne, J. A. Kemp, et al.
Controlling Polymerization of beta -Amyloid and Prion-derived Peptides with Synthetic Small Molecule Ligands
J. Biol. Chem., January 21, 2000; 275(3): 1673 - 1678.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
K. R. Bales, T. Verina, D. J. Cummins, Y. Du, R. C. Dodel, J. Saura, C. E. Fishman, C. A. DeLong, P. Piccardo, V. Petegnief, et al.
Apolipoprotein E is essential for amyloid deposition in the APPV717F transgenic mouse model of Alzheimer's disease
PNAS, December 21, 1999; 96(26): 15233 - 15238.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
K. Nishida, A. J Quantock, A. Dota, N.-H. Choi-Miura, and S. Kinoshita
Apolipoproteins J and E co-localise with amyloid in gelatinous drop-like and lattice type I corneal dystrophies
Br. J. Ophthalmol., October 1, 1999; 83(10): 1178 - 1182.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
J. T. Rogers, L. M. Leiter, J. McPhee, C. M. Cahill, S.-S. Zhan, H. Potter, and L. N. G. Nilsson
Translation of the Alzheimer Amyloid Precursor Protein mRNA Is Up-regulated by Interleukin-1 through 5'-Untranslated Region Sequences
J. Biol. Chem., March 5, 1999; 274(10): 6421 - 6431.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
P.-T. Xu, J. R. Gilbert, H.-L. Qiu, J. Ervin, T. R. Rothrock-Christian, C. Hulette, and D. E. Schmechel
Specific Regional Transcription of Apolipoprotein E in Human Brain Neurons
Am. J. Pathol., February 1, 1999; 154(2): 601 - 611.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
D. T. Weldon, S. D. Rogers, J. R. Ghilardi, M. P. Finke, J. P. Cleary, E. O'Hare, W. P. Esler, J. E. Maggio, and P. W. Mantyh
Fibrillar beta -Amyloid Induces Microglial Phagocytosis, Expression of Inducible Nitric Oxide Synthase, and Loss of a Select Population of Neurons in the Rat CNS In Vivo
J. Neurosci., March 15, 1998; 18(6): 2161 - 2173.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
A. M. Cataldo, J. L. Barnett, C. Pieroni, and R. A. Nixon
Increased Neuronal Endocytosis and Protease Delivery to Early Endosomes in Sporadic Alzheimer's Disease: Neuropathologic Evidence for a Mechanism of Increased beta -Amyloidogenesis
J. Neurosci., August 15, 1997; 17(16): 6142 - 6151.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
M. Tolar, M. A. Marques, J. A. K. Harmony, and K. A. Crutcher
Neurotoxicity of the 22 kDa Thrombin-Cleavage Fragment of Apolipoprotein E and Related Synthetic Peptides Is Receptor-Mediated
J. Neurosci., August 1, 1997; 17(15): 5678 - 5686.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. M. Hammad, S. Ranganathan, E. Loukinova, W. O. Twal, and W. S. Argraves
Interaction of Apolipoprotein J-Amyloid beta -Peptide Complex with Low Density Lipoprotein Receptor-related Protein-2/Megalin. A MECHANISM TO PREVENT PATHOLOGICAL ACCUMULATION OF AMYLOID beta -PEPTIDE
J. Biol. Chem., July 25, 1997; 272(30): 18644 - 18649.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Lalowski, A. Golabek, C. A. Lemere, D. J. Selkoe, H. M. Wisniewski, R. C. Beavis, B. Frangione, and T. Wisniewski
The "Nonamyloidogenic" p3 Fragment (Amyloid beta 17-42) Is a Major Constituent of Down's Syndrome Cerebellar Preamyloid
J. Biol. Chem., December 27, 1996; 271(52): 33623 - 33631.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L.-M. Dong and K. H. Weisgraber
Human Apolipoprotein E4 Domain Interaction. ARGININE 61AND GLUTAMIC ACID 255INTERACT TO DIRECT THE PREFERENCE FOR VERY LOW DENSITY LIPOPROTEINS
J. Biol. Chem., August 9, 1996; 271(32): 19053 - 19057.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. A. Golabek, C. Soto, T. Vogel, and T. Wisniewski
The Interaction between Apolipoprotein E and Alzheimer's Amyloid beta-Peptide Is Dependent on beta-Peptide Conformation
J. Biol. Chem., May 3, 1996; 271(18): 10602 - 10606.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
E. M. Reiman, R. J. Caselli, L. S. Yun, K. Chen, D. Bandy, S. Minoshima, S. N. Thibodeau, and D. Osborne
Preclinical Evidence of Alzheimer's Disease in Persons Homozygous for the {epsilon}4 Allele for Apolipoprotein E
N. Engl. J. Med., March 21, 1996; 334(12): 752 - 758.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
E. M. Castao, F. Prelli, M. Pras, and B. Frangione
Apolipoprotein E Carboxyl-terminal Fragments Are Complexed to Amyloids A and L
J. Biol. Chem., July 21, 1995; 270(29): 17610 - 17615.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. J. LaDu, T. M. Pederson, D. E. Frail, C. A. Reardon, G. S. Getz, and M. T. Falduto
Purification of Apolipoprotein E Attenuates Isoform-specific Binding to [IMAGE]-Amyloid
J. Biol. Chem., April 21, 1995; 270(16): 9039 - 9042.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
P. E. Fraser, A. A. Darabie, and J. McLaurin
Amyloid-beta Interactions with Chondroitin Sulfate-derived Monosaccharides and Disaccharides. IMPLICATIONS FOR DRUG DEVELOPMENT
J. Biol. Chem., February 23, 2001; 276(9): 6412 - 6419.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
Y. Huang, X. Q. Liu, T. Wyss-Coray, W. J. Brecht, D. A. Sanan, and R. W. Mahley
Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons
PNAS, July 17, 2001; 98(15): 8838 - 8843.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by the American Society for Investigative Pathology.